文献速递冠心病

定量血流分数指导与造影指导PCI在合并或不合并糖尿病患者中的比较

Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

FAVOR III China试验预设亚组分析纳入3825例PCI患者,其中1295例(33.9%)合并糖尿病。QFR指导的病变选择在糖尿病患者(6.2% vs 9.6%;HR:0.64;95%CI:0.43-0.95)和非糖尿病患者(5.6% vs 8.3%;HR:0.66;95%CI:0.49-0.89)中均降低1年MACE风险,交互作用P=0.88。

要点

  • QFR指导病变选择在合并与不合并糖尿病患者中均降低1年MACE风险。
  • 糖尿病状态不影响QFR指导的获益(交互作用P=0.88)。
  • QFR指导下延期PCI者,糖尿病与非糖尿病患者1年MACE风险相似(P=0.51)。

核心结论

  • 与标准造影指导相比,QFR指导的病变选择策略在合并和不合并糖尿病的PCI患者中均改善临床结局。

研究设计与样本

  • FAVOR III China试验预设亚组分析,共纳入3825例患者,其中1295例(33.9%)合并糖尿病,347例(26.8%)接受胰岛素治疗。
  • 糖尿病为预设的分层随机因素之一,按是否合并糖尿病比较QFR指导与造影指导PCI病变选择的临床结局。

主要发现

  • 糖尿病患者中QFR指导组与造影指导组1年MACE发生率分别为6.2%与9.6%(HR:0.64;95%CI:0.43-0.95)。
  • 非糖尿病患者中两组1年MACE发生率分别为5.6%与8.3%(HR:0.66;95%CI:0.49-0.89)。
  • 糖尿病状态与治疗策略的交互作用P=0.88。
  • QFR后延期PCI的患者中,合并与不合并糖尿病者1年MACE风险相似(4.5% vs 6.2%;P=0.51)。

关键数值与推荐

  • 主要终点为1年主要不良心血管事件(MACE),即全因死亡、心肌梗死或缺血驱动血运重建的复合终点。
  • 糖尿病合并与否的基线特征在两个治疗组间均衡。

临床怎么用

  • 在合并糖尿病的冠心病患者行PCI时,可采用QFR指导病变选择以降低1年MACE风险。
  • 不合并糖尿病的患者同样可从QFR指导的病变选择中获益。
  • QFR评估后延期PCI的决策在糖尿病与非糖尿病患者中均显示相似的1年MACE风险。

局限性

  • 原文摘要未报告该亚组分析的其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical utility of the quantitative flow ratio (QFR), a novel angiography-based index for the functional assessment of coronary stenoses, has recently been demonstrated in patients undergoing percutaneous coronary intervention (PCI). OBJECTIVES: This study aimed to ascertain whether the beneficial outcomes of QFR guidance for lesion selection during PCI is affected by diabetes status. METHODS: This substudy from the FAVOR III China trial, in which diabetes was one of the prespecified factors for stratified randomization, compared clinical outcomes of QFR-guided vs angiography-guided PCI lesion selection according to the presence of diabetes. The primary endpoint was the 1-year risk of major adverse cardiac events (MACE) (a composite of all-cause death, myocardial infarction, or ischemia-driven revascularization). RESULTS: Among 3,825 patients enrolled, 1,295 (33.9%) had diabetes, 347 (26.8%) of whom were treated with insulin. Baseline characteristics were well balanced between treatment arms in both diabetic and nondiabetic patients. Compared with standard angiography-based lesion selection, the QFR-guided strategy consistently reduced the risk of 1-year MACE in both diabetic patients (6.2% vs 9.6%; HR: 0.64; 95% CI: 0.43-0.95) and nondiabetic patients (5.6% vs 8.3%; HR: 0.66; 95% CI: 0.49-0.89) (Pinteraction = 0.88). Among patients in whom PCI was deferred after QFR, the risk of 1-year MACE was similar in patients with and without diabetes (4.5% vs 6.2%; P = 0.51). CONCLUSIONS: A QFR-guided lesion selection strategy improves PCI outcomes compared with standard angiography guidance in patients both with and without diabetes. (The Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients with Coronary Artery Disease [FAVOR III China Study]; NCT03656848).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Jin Z, Xu B, Yang X, et al. Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes. J Am Coll Cardiol. 2022. PMID: 36137676. doi:10.1016/j.jacc.2022.06.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。